EXPERIMENTAL PROCEDURES
Scientific) was used to mount the cover slips. For imaging, Nikon-N-SIM (structured illumination microscopy) was used and data were analyzed by Imaris image analysis software (Bitplane).
Protein extraction, Western blotting, and immunoprecipitation
Protein extracts were prepared in GTIP buffer (10 mM Tris, pH 7.6, 2 mM EDTA, 0.15 M NaCl) supplemented with 1% Triton TM X-100 (Roche Applied Science), 0.25% Nonidet P-40 (Roche Applied Science), complete protein inhibitor mixture (Roche Applied Science), and phosphatase inhibitors (mixture set I and set II; Calbiochem).
Detergent-soluble and -insoluble fractions were prepared as described (Gan et al. 2012; Peng et al. 2016) . Briefly, cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1 mM dithiothreitol), complete with protease inhibitors (Roche Applied Science) and 1% Triton TM X-100
(Buffer A), followed by centrifugation at 100,000 g for 30 min at 4 °C. Supernatants were recovered as Triton-soluble fractions. Pellets were washed with Buffer A three times, then resuspended in lysis buffer containing Buffer A, 1% sodium dodecyl sulfate (SDS), and 0.5% sodium deoxycholate. After sonication and a brief spin down, the lysates were recovered as Triton-insoluble (SDS-soluble) fractions.
The ER isolation was prepared with a commercial ER Enrichment kit (Novus Biologicals), according to manufacturer's protocol. Briefly, 0.5 gram liver tissue were homogenized in isosmotic homogenization buffer using a Dounce Teflon homogenizer. The homogenized tissue was centrifuged at 1,000 g for 10 min at 4 °C and then again at 12,000 g for 15 min at 4 °C. Finally, the supernatants were centrifuged at 90,000 g for 60 min at 4 °C to obtain total ER fraction. The ER fractions were subjected to Western blot analysis or immunoprecipitation.
Protein concentration was measured by the bicinchoninic acid method (Pierce). Protein electrophoresis was performed on a NuPAGE ® system using 4-12% Bis-Tris gels (Invitrogen (Pehar et al. 2012) .
Dot blots
Fractions enriched in extracellular (EC), intracellular (IC), membrane-associated (MB), or formic acid-soluble (FA) proteins were prepared as previously described (Lesne et al. 2006 rpm for 90 min at 4 °C and MB supernatants were collected. To obtain the FA fraction, remaining pellets were homogenized in 40% formic acid and agitated at room temperature for 30 min at 1,400 rpm. Tris (1M, Sigma-Aldrich) was then added to the samples, which were resuspended and centrifuged at 13,200 rpm for 90 min at 4 °C. Resulting supernatants containing formic acid-soluble proteins were collected, centrifuged for 20 min at 13,200 rpm (4 °C), and vacuum concentrated.
One microgram of liver extract enriched in either extracellular, intracellular, membrane-associated, or formic acid-soluble proteins was diluted in PBS to a total volume of 3 µL, then dotted onto a nitrocellulose membrane (Bio-Rad) and allowed to dry. Once dry, membranes were rinsed twice in TBS and incubated for one hour at room temperature in 5% BSA (Sigma-Aldrich) in TBST. Membranes were then incubated overnight at 4 °C in 5% BSA in TBST, washed four times in TBST, and incubated for one hour at room temperature in TBST with Alexa Fluor® conjugated anti-mouse secondary antibody (LICOR Biosciences). After secondary incubation, membranes were washed four additional times in TBST, rinsed once in TBS, then imaged using the LICOR Odyssey Infrared Imaging System. Fluorescent signal for each dot was quantified using OptiQuant (Packard Cyclone, Perkin-Elmer Life Sciences, Inc.).
Real-time PCR
Real-time PCR was performed as described before (Jonas et al. 2010) . Gene expression levels were normalized against GAPDH levels and expressed as percent of control. The cycling parameters were as follows: 95 °C, 10 s; 55 °C, 10s; 72 °C, 15 s, for a maximum of 45 cycles. Controls without reverse transcription were included in each assay. Specific primers used are: p21 forward (5′-GTG ATT GCG ATG CGC TCA TG-3'), p21 reverse (5′-TCT CTT GCA GAA GAC CAA TC-3'), FAM134B forward (5'-GGA CTG ACA ATG GGA CCT TC-3'), FAM134B reverse (5'-CTT GGT CTG TGA GCA CTA TCC-3'), GAPDH forward (5′-AGG TCG GTG TGA ACG GAT TTG-3'), and GAPDH reverse (5′-TGT AGA CCA TGT AGT TGA GGT CA-3').
Histology and bone histomorphometry
Hematoxylin and eosin staining was done as described before Peng et al. 2014) .
Briefly, tissues were fixed in 10% neutral buffered formalin and embedded in paraffin. Bone tissue was decalcified using a decalcifier solution (Decalcifier I, Leica Biosystems) and embedded in paraffin.
Paraffin-embedded tissues were sectioned at 5 microns and stained with hematoxylin and eosin.
Hematoxylin and eosin stained slides were examined with a Zeiss Axiovert 200 inverted microscope.
The undecalcified bone histomophometry was performed as described below. Femurs dissected from 3 month-old mice were fixed in 70% ethanol and embedded in prepolymerized polymethyl methacrylate embedding media. The embedded bones were cut at 100 microns using a Saw Microtome (SP1600, Leica Systems). The sections were then subjected to modified Goldner's trichrome staining.
Faxitron radiography and dual-energy X-ray absorptiometry (DEXA)
Bones were fixed in 70% ethanol and soft tissue was removed from the fixed bones. Radiography was performed using a Hewlett Packard Faxitron X-ray system (24 KV for 1.3 min, model 43855A; Hewlett Packard, McMinnville, OR). Bone mineral density (BMD) and total body fat mass were determined using the PIXI-mus small animal dual-energy X-ray absorptiometry (DEXA) device (Lunar) following standard manufacturer protocols. Calibrations were performed with a phantom of known density, and quality assurance measurements were performed prior to BMD measurements.
Whole blood, serum and plasma analytes
Blood was collected transcardially from mice with an insulin syringe. Hematologic parameters were measured on a HemaVet complete blood count (CBC) instrument. For serum, blood was allowed to clot on ice for 15 min, then centrifuged at 1,000 g for 10 min at 4 °C and the supernatant was collected. For plasma, blood was collected in BD Microtainer® tubes with K2EDTA and allowed to clot on ice for 15 min. Following centrifugation at 1,000 g for 10 min at 4 °C, the supernatant was collected. Ferritin and iron levels were assayed in serum using Mouse Ferritin ELISA Kit (FTL) (Abcam) and Iron Assay Kit (Abcam), respectively according to manufacturer's instructions. The lipid serum profile was performed by the UW-Clinical Laboratory. Inflammatory molecules were determined in plasma by Ampersand
Biosciences.
Blood and bone marrow smear examination
Fresh whole blood or bone marrow samples were smeared uniformly across a glass slide using another glass slide at a 30 degree smearing angle. The smeared glass slides were then air-dried and stained with PROTOCOL TM Hema 3 TM Stain kit (ThermoFisher Scientific) according to manufacturer's instructions. The Hema 3 TM stained slides were finally examined with a Zeiss Axiovert 200 inverted microscope.
Flow Cytometry
Bone marrow from WT or AT-1 sTg mice were dissociated, resuspended in PBS with 2% fetal bovine serum (FBS) and passed through a 35 µm nylon filter to obtain single-cell suspensions before antibody 
Erythroid progenitor assays
CFU assays were conducted on 8-12 week old WT and AT-1 sTg mice using 0.3 ml spleen suspension at 1 x 10 6 cells/ml mixed with 3 ml of Methocult M3434 (STEMCELL Technologies); 1.1 ml was plated in replicate 35 mm dishes. BFU-E colonies were counted 5 days after culturing. CFU-E colonies were counted 2 days after plating.
Bone marrow transplantation
Adult C57BL/6 recipient mice (CD45.1+; 6-8 weeks old) were lethally irradiated with X-ray (one dose of 8.5 Gy). Bone marrow transplantation experiments were performed as described previously (Wang et al. 2011) 
OGTT, Glucose, Insulin and Glucagon assays
Oral glucose tolerance tests (oGTT) were performed on 4-hour fasted (6am-10am) mice. Glucose (2g/kg in water) was administered via oral gavage. Blood was collected by retro-orbital collection prior to glucose administration, and at 5, 15, 30, 60, and 120 minutes following the glucose bolus. Plasma was used to determine glucose and insulin levels. Glucose was measured by the glucose oxidase method using a commercially available kit (TR15221, ThermoFisher Scientific). Insulin was measured by radioimmunoassay (RIA; SRI-13K, Millipore). Glucagon was measured by radioimmunoassay (RIA; GL-32K, Millipore).
Echocardiography
Transthoracic echocardiography was performed using a Visual Sonics 770 ultrasonography with a 30-MHz transducer (RMV 707B) (Visual Sonics, Toronto) as described previously (Harris et al. 2002) . Mice were lightly anesthetized with isoflurane (1%) and maintained on a heated platform. Two-dimensionally guided M-mode images of the LV and Doppler studies were acquired at the tip of the papillary muscles.
LV mass-to-body weight ratio (LV/BW), LV dimension in diastole (LVDd), thickness of the anterior and posterior walls in diastole, and isovolumic relaxation time were recorded. All parameters were measured over at least three consecutive cycles.
Trafficking of newly synthetized glycoproteins
Quantification of trafficking glycoproteins along the secretory pathway was performed as previously described . 
